Access to Recombinant Treatment Products
Tue, Aug 31 2004 On the 30th August the Australian Government released its response to the Senate Inquiry on Hepatitis C and the Blood Supply in Australia and announced that it would fund access to recombinant treatment products for all haemophilia patients for whom they are clinically appropriate. The media release may be accessed on the internet here
